BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19667353)

  • 1. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
    Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinocytoma shows lack of response to chemoreduction.
    Chung J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
    J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW
    Int Ophthalmol Clin; 2015; 55(1):77-96. PubMed ID: 25436495
    [No Abstract]   [Full Text] [Related]  

  • 13. Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
    All-Ericsson C; Economou MA; Landau I; Träisk F; Seregard S
    Acta Ophthalmol Scand; 2007 Aug; 85(5):569-70. PubMed ID: 17655613
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathologic changes in retinoblastoma after chemoreduction.
    Dithmar S; Aabert TM; Grossniklaus HE
    Retina; 2000; 20(1):33-6. PubMed ID: 10696744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
    Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
    Shields CL; Sun H; Manquez ME; Leahey A; Meadows AT; Shields JA
    Arch Ophthalmol; 2006 Aug; 124(8):1196-7. PubMed ID: 16908826
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical approach to management of retinoblastoma.
    Shields CL; Mashayekhi A; Demirci H; Meadows AT; Shields JA
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.